Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Impact BioMedical, INC. (IBO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Impact BioMedical, INC. (IBO), most recent 12 months reported: revenue $35K, net income $789K. Latest balance sheet on file: liquid cash $10K. From SEC filings. Others in Pharmaceutical Preparations: SILO PHARMA, INC. · LUNAI BIOWORKS INC. · ALTIMMUNE, INC. · NEONC TECHNOLOGIES HOLDINGS, INC. · Lyell Immunopharma, Inc. · BioAdaptives Inc. · JUPITER NEUROSCIENCES, INC. · Skinvisible, Inc.

Stock screener

Watchlist